
OGEN
USDOragenics Inc. Common Stock
$1.130-0.070 (-5.833%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.200
High
$1.195
Low
$1.110
Volume
0.02M
Company Fundamentals
Market Cap
4.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.15M
Exchange
ASE
Currency
USD
52-Week Range
Low $1.01Current $1.130High $18.9
Related News
BusinessWire
Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
Oragenics, Inc. (NYSE:OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, announced today that it has regained full compliance with
View more
Related Stocks
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
NASDAQ
Biotechnology: ...
UMH
UMH Properties Inc.
NASDAQ
Real Estate Inv...
AQNB
Algonquin Power & Utilities Corp. 6.20% Fixed-to-Floating Subordinated Notes Series 2019-A due July 1 2079
NASDAQ
Electric Utilit...
CTNM
Contineum Therapeutics Inc.
NASDAQ
Biotechnology: ...
COLL
Collegium Pharmaceutical Inc.
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.